Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Alliance to develop allergy treatments established by Maxygen and ALK-Abello

Feb. 23, 2001

Preparation and use of potassium channel blockers described by NeuroSearch

Feb. 22, 2001

Cognetix awarded Phase I SBIR grant to study potential asthma treatment

Feb. 22, 2001

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

Feb. 20, 2001

VLA-4 antagonists with oral activity emerge from Daiichi/Pharmacopeia collaboration

Feb. 19, 2001

Antihistaminic equivalence of cetirizine and levocetirizine demonstrated in healthy volunteers

Feb. 19, 2001

New therapeutic option for allergies available from UCB in Germany

Feb. 16, 2001

Dyax and Debiopharm move cystic fibrosis treatment into phase II

Feb. 14, 2001

Patent issued to Welfide covers new IL-4/IL-5 production inhibitors

Feb. 14, 2001

Arriva to develop ilomastat as respiratory disease treatment

Feb. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...